首页> 外文期刊>The American Journal of Tropical Medicine and Hygiene >Short report: Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India
【24h】

Short report: Clinical epidemiologic profile of a cohort of post-kala-azar dermal leishmaniasis patients in Bihar, India

机译:简短报告:印度比哈尔邦的一组黑热病后皮肤利什曼病患者的临床流行病学概况

获取原文
获取原文并翻译 | 示例
           

摘要

Post-kala-azar dermal leishmaniasis (PKDL) has important public health implications for transmission of visceral leishmaniasis (VL). Clinical and epidemiologic profiles of 102 PKDL patients showed that median age of males and females at the time of diagnosis was significantly different (P = 0.013). A significant association was observed between family history of VL and sex of PKDL patients (χ 2 = 5.72, P 0.01). Nearly 33% of the patients showed development of PKDL within one year of VL treatment. The observed time (median = 12 months) between appearance of lesions and diagnosis is an important factor in VL transmission. A significant association was observed between type of lesions and duration of appearance after VL treatment (χ 2 = 6.59, P = 0.001). Because PKDL was observed during treatment with all currently used anti-leishmanial drugs, new drug regimens having high cure rates and potential to lower the PKDL incidence need to be investigated.
机译:黑热病后皮肤利什曼病(PKDL)对内脏利什曼病(VL)的传播具有重要的公共卫生意义。 102名PKDL患者的临床和流行病学资料表明,诊断时男性和女性的中位年龄存在显着差异(P = 0.013)。 VL家族史与PKDL患者性别之间存在显着相关性(χ2 = 5.72,P <0.01)。在VL治疗的一年内,将近33%的患者表现出PKDL的发展。病变出现与诊断之间的观察时间(中位数= 12个月)是VL传播的重要因素。在VL治疗后,病变类型与出现时间之间存在显着相关性(χ2 = 6.59,P = 0.001)。因为在使用所有目前使用的抗利什曼病药物治疗期间均观察到PKDL,所以需要研究具有高治愈率和降低PKDL发病率潜力的新药物方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号